MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 189 filers reported holding MYRIAD GENETICS INC in Q4 2020. The put-call ratio across all filers is 0.81 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $566,000 | -54.4% | 43,441 | -60.3% | 0.00% | -50.0% |
Q2 2020 | $1,241,000 | -39.9% | 109,440 | +47.4% | 0.01% | -38.5% |
Q2 2019 | $2,064,000 | +2615.8% | 74,267 | +3171.7% | 0.01% | – |
Q1 2019 | $76,000 | -98.2% | 2,270 | -98.4% | 0.00% | -100.0% |
Q4 2018 | $4,184,000 | +9.4% | 143,937 | +11.2% | 0.04% | +110.5% |
Q1 2018 | $3,826,000 | -10.7% | 129,466 | +8.8% | 0.02% | -29.6% |
Q3 2017 | $4,285,000 | +62.4% | 119,017 | -5.4% | 0.03% | -51.8% |
Q4 2013 | $2,639,000 | – | 125,799 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SCOPIA CAPITAL MANAGEMENT LP | 6,459,139 | $278,776,000 | 5.53% |
Tieton Capital Management, LLC | 119,290 | $5,149,000 | 4.04% |
RPg Family Wealth Advisory, LLC | 97,202 | $4,195,238,000 | 3.85% |
RK Capital | 384,900 | $16,612,000 | 2.90% |
Contrarius Investment Management Ltd | 652,288 | $28,153,000 | 2.65% |
S&T BANK/PA | 331,885 | $14,324,000 | 2.22% |
Euclidean Technologies Management, LLC | 40,917 | $1,766,000 | 1.90% |
AIMZ Investment Advisors, LLC | 45,635 | $1,970,000 | 1.80% |
Taylor Frigon Capital Management LLC | 34,783 | $1,486,000 | 1.67% |
KILLEN GROUP INC | 366,305 | $15,810,000 | 1.63% |